NYSE - Delayed Quote USD

U.S. Physical Therapy, Inc. (USPH)

Compare
95.27 -1.83 (-1.88%)
At close: November 7 at 4:00 PM EST
95.27 0.00 (0.00%)
After hours: November 7 at 4:06 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 166.31M
Earnings 6.63M
Q4'23
Q1'24
Q2'24
Q3'24
0
50M
100M
150M
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Analyst Price Targets

100.00
104.25 Average
95.27 Current
109.00 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 6366
Avg. Estimate 0.70.532.462.88
Low Estimate 0.560.432.072.5
High Estimate 0.770.592.673.12
Year Ago EPS 0.590.512.562.46

Revenue Estimate

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 6366
Avg. Estimate 171.59M174.22M660.93M720.78M
Low Estimate 161M156.8M652M665M
High Estimate 181.04M183.18M670.17M775.21M
Year Ago Sales 154.8M155.68M604.8M660.93M
Sales Growth (year/est) 10.80%11.90%9.30%9.10%

Earnings History

CURRENCY IN USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. 0.570.560.820.68
EPS Actual 0.590.510.730.69
Difference 0.02-0.05-0.090.01
Surprise % 3.50%-8.90%-11.00%1.50%

EPS Trend

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0.70.532.462.88
7 Days Ago 0.710.532.492.93
30 Days Ago 0.710.572.562.98
60 Days Ago 0.720.572.462.95
90 Days Ago 0.760.572.843.14

EPS Revisions

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days 2122

Growth Estimates

CURRENCY IN USD USPHIndustrySectorS&P 500
Current Qtr. 18.60%----5.40%
Next Qtr. 3.90%----12.70%
Current Year -3.90%----2.10%
Next Year 17.10%----12.30%
Next 5 Years (per annum) 9.10%----11.06%
Past 5 Years (per annum) -2.21%------

Upgrades & Downgrades

Maintains Barrington Research: Outperform to Outperform 11/7/2024
Maintains Barrington Research: Outperform to Outperform 10/9/2024
Downgrade B of A Securities: Buy to Neutral 10/7/2024
Maintains Barrington Research: Outperform to Outperform 9/20/2024
Maintains Barrington Research: Outperform to Outperform 8/15/2024
Maintains Barrington Research: Outperform to Outperform 5/9/2024

Related Tickers